doi: 10.1016/j.bbabio.2009.02.021
Beyond cellular senescence, FOXO4-DRI demonstrates promise in neuroprotection, muscle regeneration, and cardiovascular health, positioning it as a keystone compound in longevity medicine (5, 6, 7)
And here we're talking about FDA approved, clinically tested peptides, but in many cases they've been clinically tested for one particular area of medicine
One of the primary metabolites of BPC-157 is thought to be Proline, which has been shown to play a role in superoxide production and intracellular cascades whose downstream effects could interfere with a variety of biomolecules leading to widespread pathologic effects [23, 51, 74, 75]
This is the most recent primary research contribution identified in the AOD9604 literature and moved the compound briefly into musculoskeletal biology, a domain separate from the adipose questions that had defined its development